Metraipolis › archive › dc_0a3bc27318ef

Emerging immunotherapeutic strategies for malignant serous effusions: current evidence and future directions — Europe PMC PMID:41646434

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646434
DOI
10.3389/fonc.2026.1757825
License (as archived)
solo-consultazione
Archived
2026-11-06T15:12:17.395Z
SHA-256 of the archived text
e5e26507a12c859807ebff8ec1e7c4f22e7bc2934b0274e83b33bb0b8746c25a
Stable URL of this page
https://metraipolis.com/documento/dc_0a3bc27318ef

How to cite

Emerging immunotherapeutic strategies for malignant serous effusions: current evidence and future directions — Europe PMC PMID:41646434 — Europe PMC (en), https://europepmc.org/article/MED/41646434 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0a3bc27318ef (Metraipolis archive dc_0a3bc27318ef, sha256 e5e26507a12c859807ebff8ec1e7c4f22e7bc2934b0274e83b33bb0b8746c25a)
BibTeX
@misc{dc0a3bc27318ef,
  title = {Emerging immunotherapeutic strategies for malignant serous effusions: current evidence and future directions — Europe PMC PMID:41646434},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646434},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0a3bc27318ef; sha256 e5e26507a12c859807ebff8ec1e7c4f22e7bc2934b0274e83b33bb0b8746c25a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646434. Agents can read the archived copy with the MCP tool read_document.